Skip to main content
A

Aloft

Aloft provides a cell biomanufacturing platform for low Earth orbit that uses microgravity to improve nutrition, gas exchange, and growth uniformity of cultured cells. Its system integrates bubble‑control, automated aeration, and uniform culture chambers with real‑time monitoring, enabling pharmaceutical and biotech firms to produce biologics and conduct experiments in space at scale.

Alachua, United StatesFounded 20243100+ followers
Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Manufacturing biologics in microgravity faces challenges such as bubble aggregation, uneven fluid dynamics, and limited control over cell health, which hinder scalable production of space‑based therapeutics.

Solution

Aloft offers a cell biomanufacturing platform designed for low Earth orbit that leverages microgravity to improve cellular nutrition, gas exchange, and growth uniformity. The system actively manages bubble formation and fluid movement, enabling reliable aeration and sparging without the complications typical of space environments. By ensuring consistent cell health and function, the platform supports large‑scale drug manufacturing and experimental workflows directly in orbit. This approach aims to expand the capacity for producing high‑quality biologics and research samples that benefit from the unique properties of microgravity.

Target Audience

Primary customers are pharmaceutical and biotechnology companies seeking to produce biologics in space, as well as space agencies and research institutions conducting cell‑based experiments in low Earth orbit.

Features

  • Integrated bubble‑control technology that prevents aggregation and maintains stable fluid interfaces in microgravity
  • Automated aeration and sparging mechanisms optimized for efficient gas exchange and nutrient delivery
  • Uniform cell culture chambers that promote consistent cell growth and viability across the entire bioreactor volume
  • Modular hardware compatible with standard low Earth orbit payload constraints
  • Real‑time monitoring of fluid dynamics and cell health parameters for remote operation and data collection
This profile is AI-generated and may contain inaccuracies.